MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to Debentureholders

Core Points - MustGrow Biologics Corp. announced a non-brokered private placement offering of up to $3 million through the sale of 4,285,715 units at a price of $0.70 per unit [1] - The offering includes a proposed repricing of existing warrants and a shares-for-debt settlement offer to debentureholders [1][10] - The net proceeds from the offering will be used for inventory production of its organic biofertility product TerraSanteTM, agricultural product inventory, and general corporate purposes [3] LIFE Offering - Each unit in the LIFE Offering consists of one common share and one common share purchase warrant, with the warrant exercisable at $0.90 for 60 months [2] - The offering is expected to close around August 21, 2025, subject to necessary approvals [6] Warrant Repricing - The company plans to reprice 1,721,610 outstanding warrants from an exercise price of $1.90 to $0.90, with an expiry date of January 16, 2030 [10] - An acceleration provision will be included, allowing for a 30-day exercise period if the share price exceeds $1.08 for ten consecutive trading days [11] Shares for Debenture Debt Settlement - MustGrow intends to offer shares to settle up to $2,585,000 in outstanding principal on unsecured convertible debentures, issuing approximately 3,692,860 shares at a deemed price of $0.70 each [13] - The settlement shares will also be subject to a statutory hold period of four months and one day from issuance [14] Company Overview - MustGrow Biologics Corp. provides innovative biological and regenerative agriculture solutions, focusing on eco-friendly alternatives to synthetic chemicals and fertilizers [18] - The company has a portfolio of approximately 112 patents and collaborates with agriculture companies like Bayer AG for commercialization [18]